Indication

Fusospirochetal pharyngitis

Fusospirochetal pharyngitis, also known as Vincent's angina or acute necrotizing ulcerative tonsillopharyngitis, is an acute polymicrobial infection involving the pharynx and palatine tonsils. Read more about Fusospirochetal pharyngitis

83 drugs 53 manufacturers

Advertisement

Drugs that treat it

Common Fusospirochetal pharyngitis therapies.

Showing 37–45 of 83 drugs

Filter & compare in the drug finder →Opens the drug finder with Fusospirochetal pharyngitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Fusospirochetal pharyngitis.

Fusospirochetal pharyngitis, also known as Vincent's angina or acute necrotizing ulcerative tonsillopharyngitis, is an acute polymicrobial infection involving the pharynx and palatine tonsils.

Pathophysiologically, it is driven by an opportunistic, synergistic overgrowth of anaerobic fusiform bacilli, predominantly *Fusobacterium necrophorum* or *Fusobacterium nucleatum*, and oral spirochetes such as *Treponema* species, frequently arising in hosts with poor dentition, physical exhaustion, malnutrition, or relative immunocompromise.

Clinically, it most often presents in adolescents and adults with severe sore throat, painful swallowing, foul-smelling breath, regional cervical lymphadenopathy, and characteristically unilateral tonsillopharyngeal ulcerations covered by a dirty-gray, necrotic pseudomembrane.

Personalize your experience

Follow Fusospirochetal pharyngitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it